Centre for Cellular and Molecular Platforms (C-CAMP)

Vitas M Chemical (trademark Vitas-M Laboratory) has a good reputation as a supplier of small molecule organic compounds for research and development in pharmaceutical and agrochemical industry. We are on the market since 1998.

Our compounds are suitable for biological screening, lead optimization, fragment based drug discovery (FBDD), computer aided drug design (CADD), virtual docking, combinatorial chemistry and for other types of investigations in the field of Medicinal Chemistry and Molecular Biology. We carry stock of more than 1 400 000 compounds which is available for downloading from our web site.

All substances are available for searching and ordering in our web based search engine. Just visit our web site.

If you are in medicinal chemistry area take a look at collection of Fragments (chemical substances passed through "Rule of 3"​ and other special filters) for Fragments Based Drug Discovery (Allium Project).
If you are looking for special libraries of compounds for your research, we offer diversity and targeted libraries. They are calculated using modern computational algorithms, which allows to optimize efficiency and reduce potential complications of drug discovery process.

All compounds can be delivered in any format including mg, micromole, dry powder, DMSO solution, dry film.

Contact: irina@vitasmlab.biz

Asiatic aims to be a pioneer in emerging as one of India's first hybrid CRO that integrates technology and nurtures captive sites from tier II/III cities to bring a larger pool of investigators and patients into the clinical research world that would enable quicker new drug development.

AXIS Clinicals Limited is one of the most experienced and fastest growing Clinical Research Organization.

Our state-of-the-art facilities houses 500+ dedicated full-time professionals to ensure the quick turn around time with high quality. Our facilities are accredited by DCGI (Drugs Controller General – India), NABL (National Accreditation Board for Testing and Calibration Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA, France –AFSSAPS / ANSM, GCC, MCC-South Africa etc.

Within short span, we have achieved the milestone of completing 2750+ clinical studies and 1000+ product approvals from various regulatory agencies.

65+ regulatory audits from global competent authorities is testament to our professionalism and dedication to quality studies.

Our Phase II – IV capabilities are growing along with an extended portfolio of Site Management, Medical Writing, and Data Management.

Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research, Lab services, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs).

Cliantha, by leveraging on the depth of experience provides ethical, value added customer centric services rooted in excellence, thereby enabling clinical development of pharmaceutical, biotech & healthcare companies.

With strategic acquisitions globally, Cliantha has widened the horizon of clinical research & support services for end-to-end developmental needs all across. The company merged its group companies Inflamax Research, Hilltop Research, and Solvius LLP under one flagship brand – Cliantha.

With several advanced clinical sites and bio-analytical laboratories in North America and India, Cliantha now has presence in 4 countries along with a strong team of 1000+ professionals. Some of the key regulators, such as the USFDA, EMA, AGES, ANSM, AMPS, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey MOH, Thailand MoPH and others have successfully inspected Cliantha across the globe.

Cliantha Research is headquartered in Ahmedabad and has expanded its domestic reach with 5 regional offices & has presence in USA (Florida & New Jersey), Canada (Mississauga, Winnipeg & Scarborough) & Europe (Portugal)

CliniRx is a global Clinical Research Organisation with deep regional experience. CliniRx offers ICH-GCP compliant clinical trial services from Phase I – IV in key therapeutic areas to support clinical development requirements. We have offices and operational capabilities in India, US and UK.

We offer end to end services starting from conduct of Feasibility Studies, Study Planning to Regulatory Submissions, Site Evaluation and Selection, Site Monitoring, Project Management, Medical Monitoring, Pharmacovigilance, Clinical Data Management, Data Analysis, Medical Writing and Quality Assurance.